Evidence-based clinical practice guidelines for cholelithiasis 2021.

Cholelithiasis Common bile duct stones Endoscopic treatment Gallbladder stones Intrahepatic stones Surgical treatment

Journal

Journal of gastroenterology
ISSN: 1435-5922
Titre abrégé: J Gastroenterol
Pays: Japan
ID NLM: 9430794

Informations de publication

Date de publication:
09 2023
Historique:
received: 26 04 2023
accepted: 21 06 2023
medline: 16 8 2023
pubmed: 15 7 2023
entrez: 15 7 2023
Statut: ppublish

Résumé

The Japanese Society of Gastroenterology first published evidence-based clinical practice guidelines for cholelithiasis in 2010, followed by a revision in 2016. Currently, the revised third edition was published to reflect recent evidence on the diagnosis, treatment, and prognosis of cholelithiasis conforming to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Following this revision, the present English version of the guidelines was updated and published herein. The clinical questions (CQ) in the previous version were reviewed and rearranged into three newly divided categories: background questions (BQ) dealing with basic background knowledge, CQ, and future research questions (FRQ), which refer to issues that require further accumulation of evidence. Finally, 52 questions (29 BQs, 19 CQs, and 4 FRQs) were adopted to cover the epidemiology, pathogenesis, diagnosis, treatment, complications, and prognosis. Based on a literature search using MEDLINE, Cochrane Library, and Igaku Chuo Zasshi databases for the period between 1983 and August 2019, along with a manual search of new information reported over the past 5 years, the level of evidence was evaluated for each CQ. The strengths of recommendations were determined using the Delphi method by the committee members considering the body of evidence, including benefits and harms, patient preference, and cost-benefit balance. A comprehensive flowchart was prepared for the diagnosis and treatment of gallbladder stones, common bile duct stones, and intrahepatic stones, respectively. The current revised guidelines are expected to be of great assistance to gastroenterologists and general physicians in making decisions on contemporary clinical management for cholelithiasis patients.

Identifiants

pubmed: 37452855
doi: 10.1007/s00535-023-02014-6
pii: 10.1007/s00535-023-02014-6
pmc: PMC10423145
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

801-833

Informations de copyright

© 2023. The Author(s).

Références

Tazuma S, Unno M, Igarashi Y, et al. Evidence-based clinical practice guidelines for cholelithiasis 2016. J Gastroenterol. 2017;52:276–300.
pubmed: 27942871 doi: 10.1007/s00535-016-1289-7
Minds Manual Developing Committee. Minds Manual for Guideline Development 2017. Tokyo: Japan Council for Quality Health Care; 2017. (in Japanese)
Qaseem A, Kansagara D, Lin JS, et al. The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods. Ann Intern Med. 2019;170:863–70.
pubmed: 31181568 doi: 10.7326/M18-3290
Yoshida M, Kinoshita Y, Watanabe M, et al. JSGE Clinical Practice Guidelines 2014: standards, methods, and process of developing the guidelines. J Gastroenterol. 2015;50:4–10.
pubmed: 25448314 doi: 10.1007/s00535-014-1016-1
Health Statistics Association of Japan. Estimated number of patients based on patient surveys. Index of Health. 1993;39:29–35 (in Japanese).
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.
pubmed: 12711737 doi: 10.1056/NEJMoa021423
Kameda H, Kozuki T, Tanimura H, et al. Report of cholelithiasis investigation committee of the Japan Biliary Association. J Jpn Biliary Assoc. 1990;4:396–404 (in Japanese with English abstract).
Tanimura H, Uchiyama K. Report on the results of the national survey on cholelithiasis 1996. J Jpn Biliary Assoc. 1997;11:133–140 (in Japanese with English abstract)
The Japanese Biliary Society Cholelithiasis Survey Project. National cholelithiasis survey report 1997. J Jpn Biliary Assoc. 1997;1998(12):276–93 (in Japanese).
Committee JBA. Report on the 2013 National Survey for biliary stone. J Jpn Biliary Assoc. 2014;28:612–7 (in Japanese).
Suzuki Y, Mori T, Yokoyama M, et al. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years. J Hepatobiliary Pancreat Sci. 2014;21:617–22.
pubmed: 24824191 doi: 10.1002/jhbp.116
Hay DW, Carey MC. Pathophysiology and pathogenesis of cholesterol gallstone formation. Semin Liver Dis. 1990;10:159–70.
pubmed: 2218580 doi: 10.1055/s-2008-1040470
Shoda J. Classification and pathogenesis of gallstones. J Jpn Biliary Assoc. 2013;27:672–679 (in Japanese with English abstract)
Ko CW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med. 1999;130:301–11.
pubmed: 10068389 doi: 10.7326/0003-4819-130-4-199902160-00016
Jonkers IJ, Smelt AH, Ledeboer M, et al. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut. 2003;52:109–15.
pubmed: 12477770 pmcid: 1773519 doi: 10.1136/gut.52.1.109
Carey MC. Pathogenesis of gallstones. Am J Surg. 1993;165:410–9.
pubmed: 8480873 doi: 10.1016/S0002-9610(05)80932-8
Vitek L, Carey MC. New pathophysiological concepts underlying pathogenesis of pigment gallstones. Clin Res Hepatol Gastroenterol. 2012;36:122–9.
pubmed: 21978438 doi: 10.1016/j.clinre.2011.08.010
Ise H, Moriyasu A, Suzuki N, et al. Pathogenesis of black stones. J Hepatobiliary Pancreat Surg. 1997;4:412–6.
doi: 10.1007/BF02488974
Vitek L, Carey MC. Enterohepatic cycling of bilirubin as a cause of “black” pigment gallstones in adult life. Eur J Clin Invest. 2003;33:799–810.
pubmed: 12925040 doi: 10.1046/j.1365-2362.2003.01214.x
Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7:132–40.
pubmed: 15802102 doi: 10.1007/s11894-005-0051-8
Stampfer MJ, Maclure KM, Colditz GA, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652–8.
pubmed: 1550039 doi: 10.1093/ajcn/55.3.652
Halpern Z, Rubin M, Harach G, et al. Bile and plasma lipid composition in non-obese normolipidemic subjects with and without cholesterol gallstones. Liver. 1993;13:246–52.
pubmed: 8259036 doi: 10.1111/j.1600-0676.1993.tb00639.x
Kim HS, Cho SK, Kim CS, et al. Big data and analysis of risk factors for gallbladder disease in the young generation of Korea. PLoS ONE. 2019;14: e0211480.
pubmed: 30794560 pmcid: 6386282 doi: 10.1371/journal.pone.0211480
Méndez-Sánchez N, Zamora-Valdés D, Chávez-Tapia NC, et al. Role of diet in cholesterol gallstone formation. Clin Chim Acta. 2007;376:1–8.
pubmed: 17055469 doi: 10.1016/j.cca.2006.08.036
Cuevas A, Miquel JF, Reyes MS, et al. Diet as a risk factor for cholesterol gallstone disease. J Am Coll Nutr. 2004;23:187–96.
pubmed: 15190042 doi: 10.1080/07315724.2004.10719360
Barbara L, Sama C, Labate AMM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology. 1987;7:913–7.
pubmed: 3653855 doi: 10.1002/hep.1840070520
Grodstein F, Colditz GA, Hunter DJ, et al. A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet Gynecol. 1994;84:207–14.
pubmed: 8041531
Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med. 1993;119:1029–35.
pubmed: 8214980 doi: 10.7326/0003-4819-119-10-199311150-00010
Ohya T, Tazuma S. Pathogenesis of Gallstone and Pancreatic Stone Formation. Endoscopia Digestiva. 2019;31:1594–1600 (in Japanese with English abstract).
Tsai C-J, Leitzmann MF, Willett WC, et al. Macronutrients and insulin resistance in cholesterol gallstone disease. Off J Am Coll Gastroenterol ACG. 2008;103:2932–9.
doi: 10.1111/j.1572-0241.2008.02189.x
Thomas LA, Veysey MJ, Bathgate T, et al. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology. 2000;119:806–15.
pubmed: 10982775 doi: 10.1053/gast.2000.16495
Colecchia A, Mazzella G, Sandri L, et al. Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients. World J Gastroenterol. 2006;12:5336.
pubmed: 16981264 pmcid: 4088201 doi: 10.3748/wjg.v12.i33.5336
Gustafsson U, Benthin L, Granström L, et al. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology. 2005;41:1322–8.
pubmed: 15834935 doi: 10.1002/hep.20686
Asai Y, Yamada T, Tsukita S, et al. Activation of the hypoxia inducible factor 1α subunit pathway in steatotic liver contributes to formation of cholesterol gallstones. Gastroenterology. 2017;152(1521–1535): e8.
Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology. 1985;88:787–91.
pubmed: 3967810 doi: 10.1016/0016-5085(85)90152-0
Pauletzki J, Althaus R, Holl J, et al. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology. 1996;111:765–71.
pubmed: 8780583 doi: 10.1053/gast.1996.v111.pm8780583
Portincasa P, Di Ciaula A, Wang HH, et al. Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology. 2008;47:2112–26.
pubmed: 18506897 doi: 10.1002/hep.22204
Inoue K, Fuchigami A, Higashide S, et al. Gallbladder sludge and stone formation in relation to contractile function after gastrectomy. A prospective study. Ann Surg. 1992;215:19.
pubmed: 1731646 pmcid: 1242365 doi: 10.1097/00000658-199201000-00002
Shoda J, He B-F, Tanaka N, et al. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology. 1995;21:1291–302.
pubmed: 7737634
Tsai C-J, Leitzmann MF, Hu FB, et al. A prospective cohort study of nut consumption and the risk of gallstone disease in men. Am J Epidemiol. 2004;160:961–8.
pubmed: 15522852 doi: 10.1093/aje/kwh302
Leitzmann MF, Stampfer MJ, Willett WC, et al. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology. 2002;123:1823–30.
pubmed: 12454839 doi: 10.1053/gast.2002.37054
Festi D, Colecchia A, Orsini M, et al. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes. 1998;22:592–600.
doi: 10.1038/sj.ijo.0800634
Cha BH, Jang M-j, Lee SH. Alcohol consumption can reduce the risk of gallstone disease: a systematic review with a dose-response meta-analysis of case-control and cohort studies. Gut Liver. 2019;13:114.
pubmed: 30665280 pmcid: 6346994 doi: 10.5009/gnl18278
Leitzmann MF, Rimm EB, Willett WC, et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med. 1999;341:777–84.
pubmed: 10477775 doi: 10.1056/NEJM199909093411101
Shoda J, Miyamoto J, Kano M, et al. Simultaneous determination of plasma mevalonate and 7 α-hydroxy-4-cholesten-3-one levels in hyperlipoproteinemia: Convenient indices for estimating hepatic defects of cholesterol and bile acid syntheses and biliary cholesterol supersaturation. Hepatology. 1997;25:18–26.
pubmed: 8985259
Tsai CJ, Leitzmann MF, Willett WC, et al. Statin use and the risk of cholecystectomy in women. Gastroenterology. 2009;136:1593–600.
pubmed: 19208351 doi: 10.1053/j.gastro.2009.01.042
Festi D, Frabboni R, Bazzoli F, et al. Gallbladder motility in cholesterol gallstone disease: effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology. 1990;99:1779–85.
pubmed: 2227291 doi: 10.1016/0016-5085(90)90487-L
Veysey M, Malcolm P, Mallet A, et al. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial. Gut. 2001;49:828–34.
pubmed: 11709518 pmcid: 1728548 doi: 10.1136/gut.49.6.828
Shoda J. Natural History of Gallstones. J Jpn Biliary Assoc. 2017;31:187–195 (in Japanese with English abstract)
Festi D, Reggiani MLB, Attili AF, et al. Natural history of gallstone disease: expectant management or active treatment? Results from a population-based cohort study. J Gastroenterol Hepatol. 2010;25:719–24.
pubmed: 20492328 doi: 10.1111/j.1440-1746.2009.06146.x
Shabanzadeh DM, Sorensen LT, Jorgensen T. A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study. Gastroenterology. 2016;150(156–167): e1.
Persson GE. Expectant management of patients with gallbladder stones diagnosed at planned investigation. A prospective 5- to 7-year follow-up study of 153 patients. Scand J Gastroenterol. 1996;31:191–9.
pubmed: 8658043 doi: 10.3109/00365529609031985
Dworken HJ. Recent experiences with spontaneously disappearing gallstones. Gastroenterology. 1960;38:76–86.
pubmed: 13818962 doi: 10.1016/S0016-5085(60)80120-5
Norman CH Jr, Butera DG. Spontaneously disappearing gallstones. J Natl Med Assoc. 1979;71:61.
pubmed: 423277 pmcid: 2537225
Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg. 1993;165:399–404.
pubmed: 8480871 doi: 10.1016/S0002-9610(05)80930-4
Thistle JL, Cleary PA, Lachin JM, et al. The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med. 1984;101:171–5.
pubmed: 6742647 doi: 10.7326/0003-4819-101-2-171
Lamberts MP, Ozdemir C, Drenth JPH, et al. Cost-effectiveness of a new strategy to identify uncomplicated gallstone disease patients that will benefit from a cholecystectomy. Surg Endosc. 2017;31:2534–40.
pubmed: 27655382 doi: 10.1007/s00464-016-5256-4
Brazzelli M, Cruickshank M, Kilonzo M, et al. Systematic review of the clinical and cost effectiveness of cholecystectomy versus observation/conservative management for uncomplicated symptomatic gallstones or cholecystitis. Surg Endosc. 2015;29:637–47.
pubmed: 25119541 doi: 10.1007/s00464-014-3712-6
Schmidt M, Sondenaa K, Vetrhus M, et al. A randomized controlled study of uncomplicated gallstone disease with a 14-year follow-up showed that operation was the preferred treatment. Dig Surg. 2011;28:270–6.
pubmed: 21757915 doi: 10.1159/000329464
Cariati A, Piromalli E, Cetta F. Gallbladder cancers: associated conditions, histological types, prognosis, and prevention. Eur J Gastroenterol Hepatol. 2014;26:562–9.
pubmed: 24614695 doi: 10.1097/MEG.0000000000000074
Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA. 1983;250:2323–6.
pubmed: 6632129 doi: 10.1001/jama.1983.03340170049027
Lowenfels AB, Lindstrom CG, Conway MJ, et al. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst. 1985;75:77–80.
pubmed: 3859698
Nervi F, Duarte I, Gomez G, et al. Frequency of gallbladder cancer in Chile, a high-risk area. Int J Cancer. 1988;41:657–60.
pubmed: 3366486 doi: 10.1002/ijc.2910410503
WHO. Combined oral contraceptives and gallbladder cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol. 1989;18:309–14.
Kato K, Akai S, Tominaga S, et al. A case-control study of biliary tract cancer in Niigata Prefecture. Japan Jpn J Cancer Res. 1989;80:932–8.
pubmed: 2515177
Kimura W, Shimada H, Kuroda A, et al. Carcinoma of the gallbladder and extrahepatic bile duct in autopsy cases of the aged, with special reference to its relationship to gallstones. Am J Gastroenterol. 1989;84:386–90.
pubmed: 2929559
Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst. 1997;89:1132–8.
pubmed: 9262251 doi: 10.1093/jnci/89.15.1132
Okamoto M, Okamoto H, Kitahara F, et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am J Gastroenterol. 1999;94:446–50.
pubmed: 10022644 doi: 10.1111/j.1572-0241.1999.875_d.x
Khan ZR, Neugut AI, Ahsan H, et al. Risk factors for biliary tract cancers. Am J Gastroenterol. 1999;94:149–52.
pubmed: 9934746 doi: 10.1111/j.1572-0241.1999.00786.x
Scott TE, Carroll M, Cogliano FD, et al. A case-control assessment of risk factors for gallbladder carcinoma. Dig Dis Sci. 1999;44:1619–25.
pubmed: 10492143 doi: 10.1023/A:1026675329644
Csendes A, Becerra M, Rojas J, et al. Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma: a prospective study of 592 cases. J Gastrointest Surg. 2000;4:481–5.
pubmed: 11077323 doi: 10.1016/S1091-255X(00)80090-6
Serra I, Yamamoto M, Calvo A, et al. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer. 2002;102:407–11.
pubmed: 12402311 doi: 10.1002/ijc.10716
Roa I, Ibacache G, Roa J, et al. Gallstones and gallbladder cancer-volume and weight of gallstones are associated with gallbladder cancer: a case-control study. J Surg Oncol. 2006;93:624–8.
pubmed: 16724353 doi: 10.1002/jso.20528
Ahrens W, Timmer A, Vyberg M, et al. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study. Eur J Gastroenterol Hepatol. 2007;19:623–30.
pubmed: 17625430 doi: 10.1097/01.meg.0000243876.79325.a1
Grainge MJ, West J, Solaymani-Dodaran M, et al. The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer. 2009;100:178–80.
pubmed: 19018260 doi: 10.1038/sj.bjc.6604765
Alvi AR, Siddiqui NA, Zafar H. Risk factors of gallbladder cancer in Karachi-a case-control study. World J Surg Oncol. 2011;9:164.
pubmed: 22151791 pmcid: 3256117 doi: 10.1186/1477-7819-9-164
Maringhini A, Moreau JA, Melton LJ 3rd, et al. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med. 1987;107:30–5.
pubmed: 3592446 doi: 10.7326/0003-4819-107-1-30
Chow WH, Johansen C, Gridley G, et al. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer. 1999;79:640–4.
pubmed: 10027343 pmcid: 2362428 doi: 10.1038/sj.bjc.6690101
Ishiguro S, Inoue M, Kurahashi N, et al. Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification. Cancer Causes Control. 2008;19:33–41.
pubmed: 17906958 doi: 10.1007/s10552-007-9067-8
Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–602.
pubmed: 16397865 doi: 10.1002/ijc.21683
Yagyu K, Lin Y, Obata Y, et al. Bowel movement frequency, medical history and the risk of gallbladder cancer death: a cohort study in Japan. Cancer Sci. 2004;95:674–8.
pubmed: 15298731 doi: 10.1111/j.1349-7006.2004.tb03328.x
Schnelldorfer T. Porcelain gallbladder: a benign process or concern for malignancy? J Gastrointest Surg. 2013;17:1161–8.
pubmed: 23423431 doi: 10.1007/s11605-013-2170-0
Nomura Y, Inui K, Yoshino J, et al. Causes of cholelithiasis, epidemiology, gallbladder stones and gallbladder cancer. Naika. 2005;95:223–6 (in Japanese).
Otani K, Chijiiwa K, Ouchida J, et al. Indications for resection of cholelithiasis and gallbladder polyps. Surgery. 2009;71:29–33.
Horiguchi Y, Sakamoto K, Harada M, et al. Treatment of cholelithiasis: The natural history and treatment strategy for asymptomatic gallbladder stones. Naika. 2005;95:251–4 (in Japanese).
Koga A, Ichimiya H, Yamaguchi K, et al. Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance Cancer. 1985;55:2826–9.
pubmed: 2986827
Chen MF, Jan YY, Wang CS, et al. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer. 1993;71:2461–5.
pubmed: 8384069 doi: 10.1002/1097-0142(19930415)71:8<2461::AID-CNCR2820710806>3.0.CO;2-7
Sheen-Chen SM, Chou FF, Eng HL. Intrahepatic cholangiocarcinoma in hepatolithiasis: a frequently overlooked disease. J Surg Oncol. 1991;47:131–5.
pubmed: 1648151 doi: 10.1002/jso.2930470213
Kawarada Y, Mita T. Cholangiocarcinoma associated with hepatolithiasis. Tan to Sui. 1994;15:435–46 (in Japanese).
Chijiiwa K, Yamashita H, Yoshida J, et al. Current management and long-term prognosis of hepatolithiasis. Arch Surg. 1995;130:194–7.
pubmed: 7848091 doi: 10.1001/archsurg.1995.01430020084016
Kubo S, Kinoshita H, Hirohashi K, et al. Hepatolithiasis associated with cholangiocarcinoma. World J Surg. 1995;19:637–41.
pubmed: 7676713 doi: 10.1007/BF00294744
Liu CL, Fan ST, Wong J. Primary biliary stones: diagnosis and management. World J Surg. 1998;22:1162–6.
pubmed: 9828725 doi: 10.1007/s002689900536
Chen DW, Tung-Ping Poon R, Liu CL, et al. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery. 2004;135:386–93.
pubmed: 15041962 doi: 10.1016/j.surg.2003.09.007
Cheung MT, Kwok PC. Liver resection for intrahepatic stones. Arch Surg. 2005;140:993–7.
pubmed: 16230551 doi: 10.1001/archsurg.140.10.993
Vetrone G, Ercolani G, Grazi GL, et al. Surgical therapy for hepatolithiasis: a Western experience. J Am Coll Surg. 2006;202:306–12.
pubmed: 16427557 doi: 10.1016/j.jamcollsurg.2005.09.022
Lee TY, Chen YL, Chang HC, et al. Outcomes of hepatectomy for hepatolithiasis. World J Surg. 2007;31:479–82.
pubmed: 17334864 doi: 10.1007/s00268-006-0441-6
Al-Sukhni W, Gallinger S, Pratzer A, et al. Recurrent pyogenic cholangitis with hepatolithiasis–the role of surgical therapy in North America. J Gastrointest Surg. 2008;12:496–503.
pubmed: 17999121 doi: 10.1007/s11605-007-0398-2
Cheon YK, Cho YD, Moon JH, et al. Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis. Surgery. 2009;146:843–53.
pubmed: 19744434 doi: 10.1016/j.surg.2009.04.009
Uenishi T, Hamba H, Takemura S, et al. Outcomes of hepatic resection for hepatolithiasis. Am J Surg. 2009;198:199–202.
pubmed: 19249730 doi: 10.1016/j.amjsurg.2008.08.020
Tabrizian P, Jibara G, Shrager B, et al. Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg. 2012;215:622–6.
pubmed: 22921329 doi: 10.1016/j.jamcollsurg.2012.07.005
Suzuki Y, Mori T, Abe N, et al. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study. Hepatol Res. 2012;42:166–70.
pubmed: 22151748 doi: 10.1111/j.1872-034X.2011.00908.x
Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. Eur J Surg Oncol. 2014;40:567–75.
pubmed: 24388409 doi: 10.1016/j.ejso.2013.12.006
Zhu QD, Zhou MT, Zhou QQ, et al. Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma. World J Surg. 2014;38:2097–104.
pubmed: 24519588 doi: 10.1007/s00268-014-2476-4
Furukawa M, Sasaki M, Ohtsubo M, et al. Natural history of primary hepatolithiasis. Tan to Sui. 1998;19:1021–7 (in Japanese).
Jo JH, Chung MJ, Park JY, et al. High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study. Surg Endosc. 2013;27:4210–6.
pubmed: 23760942 doi: 10.1007/s00464-013-3025-1
Liu ZY, Zhou YM, Shi LH, et al. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. Hepatobiliary Pancreat Dis Int. 2011;10:626–31.
pubmed: 22146627 doi: 10.1016/S1499-3872(11)60106-9
Suzuki Y, Mori T, Yokoyama M, et al. Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study Journal of Japan Biliary Association. 2013;27:700–704 (in Japanese with English abstract)
Chijiiwa K, Ichimiya H, Kuroki S, et al. Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet. 1993;177:279–82.
pubmed: 8395085
Jan YY, Chen MF, Wang CS, et al. Surgical treatment of hepatolithiasis: long-term results. Surgery. 1996;120:509–14.
pubmed: 8784405 doi: 10.1016/S0039-6060(96)80071-7
Huang MH, Chen CH, Yang JC, et al. Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis. Am J Gastroenterol. 2003;98:2655–62.
pubmed: 14687812 doi: 10.1111/j.1572-0241.2003.08770.x
Li SQ, Liang LJ, Peng BG, et al. Outcomes of liver resection for intrahepatic stones: a comparative study of unilateral versus bilateral disease. Ann Surg. 2012;255:946–53.
pubmed: 22504194 doi: 10.1097/SLA.0b013e31824dedc2
Lin CC, Lin PY, Chen YL. Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: clinical implications. World J Gastroenterol. 2013;19:375–80.
pubmed: 23372360 pmcid: 3554822 doi: 10.3748/wjg.v19.i3.375
Tsuyuguchi T, Miyakawa K, Sugiyama H, et al. Ten-year long-term results after non-surgical management of hepatolithiasis, including cases with choledochoenterostomy. J Hepatobiliary Pancreat Sci. 2014;21:795–800.
pubmed: 25070702 doi: 10.1002/jhbp.134
Kim HJ, Kim JS, Suh SJ, et al. Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients. World J Surg. 2015;39:1537–42.
pubmed: 25648078 doi: 10.1007/s00268-015-2965-0
Meng ZW, Han SH, Zhu JH, et al. Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones. World J Surg. 2017;41:835–43.
pubmed: 27766397 doi: 10.1007/s00268-016-3752-2
Kim HJ, Kang TU, Swan H, et al. Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones. Dig Dis Sci. 2018;63:3465–73.
pubmed: 30171402 doi: 10.1007/s10620-018-5262-6
Gibney EJ. Asymptomatic gallstones. Br J Surg. 1990;77:368–72.
pubmed: 2187558 doi: 10.1002/bjs.1800770405
Portincasa P, Moschetta A, Petruzzelli M, et al. Gallstone disease: symptoms and diagnosis of gallbladder stones. Best Pract Res Clin Gastroenterol. 2006;20:1017–29.
pubmed: 17127185 doi: 10.1016/j.bpg.2006.05.005
Tomida S, Abei M, Yamaguchi T, et al. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology. 1999;30:6–13.
pubmed: 10385632 doi: 10.1002/hep.510300108
Tazuma S, Kanno K, Kubota K, et al. Report on the 2013 national cholelithiasis survey in Japan. J Hepatobiliary Pancreat Sci. 2015;22:392–5.
pubmed: 25597597 doi: 10.1002/jhbp.206
Peng WK, Sheikh Z, Paterson-Brown S, et al. Role of liver function tests in predicting common bile duct stones in acute calculous cholecystitis. Br J Surg. 2005;92:1241–7.
pubmed: 16078299 doi: 10.1002/bjs.4955
Barakos JA, Ralls PW, Lapin SA, et al. Cholelithiasis: evaluation with CT. Radiology. 1987;162:415–8.
pubmed: 3797654 doi: 10.1148/radiology.162.2.3797654
Neitlich T, Neitlich J. The imaging evaluation of cholelithiasis in the obese patient-ultrasound vs CT cholecystography: our experience with the bariatric surgery population. Obes Surg. 2009;19:207–10.
pubmed: 18633683 doi: 10.1007/s11695-008-9582-z
Ito K, Fujita N, Noda Y, et al. [The significance of magnetic resonance cholangiopancreatography in acute cholecystitis]. Nihon Shokakibyo Gakkai Zasshi. 2000;97:1472–9 (in Japanese with English abstract)
Dahan P, Andant C, Levy P, et al. Prospective evaluation of endoscopic ultrasonography and microscopic examination of duodenal bile in the diagnosis of cholecystolithiasis in 45 patients with normal conventional ultrasonography. Gut. 1996;38:277–81.
pubmed: 8801211 pmcid: 1383037 doi: 10.1136/gut.38.2.277
Yokoe M, Takada T, Strasberg SM, et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19:578–85.
pubmed: 22872303 pmcid: 3429769 doi: 10.1007/s00534-012-0548-0
Naidu K, Beenen E, Gananadha S, et al. The yield of fever, inflammatory markers and ultrasound in the diagnosis of acute cholecystitis: a validation of the 2013 Tokyo guidelines. World J Surg. 2016;40:2892–7.
pubmed: 27460142 doi: 10.1007/s00268-016-3660-5
Yokoe M, Takada T, Hwang TL, et al. Descriptive review of acute cholecystitis: Japan-Taiwan collaborative epidemiological study. J Hepatobiliary Pancreat Sci. 2017;24:319–28.
pubmed: 28316140 doi: 10.1002/jhbp.450
Gruber PJ, Silverman RA, Gottesfeld S, et al. Presence of fever and leukocytosis in acute cholecystitis. Ann Emerg Med. 1996;28:273–7.
pubmed: 8780469 doi: 10.1016/S0196-0644(96)70025-2
Strasberg SM. Clinical practice. Acute calculous cholecystitis. N Engl J Med. 2008;358:2804–11.
pubmed: 18579815 doi: 10.1056/NEJMcp0800929
Yokoe M, Takada T, Strasberg SM, et al. TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2013;20:35–46.
pubmed: 23340953 doi: 10.1007/s00534-012-0568-9
Hammarstrom L, Ranstam J. Factors predictive of bile duct stones in patients with acute calculous cholecystitis. Dig Surg. 1998;15:323–7.
pubmed: 9845607 doi: 10.1159/000018646
Yarmish GM, Smith MP, Rosen MP, et al. ACR appropriateness criteria right upper quadrant pain. J Am Coll Radiol. 2014;11:316–22.
pubmed: 24485592 pmcid: 4332791 doi: 10.1016/j.jacr.2013.11.017
Pinto A, Reginelli A, Cagini L, et al. Accuracy of ultrasonography in the diagnosis of acute calculous cholecystitis: review of the literature. Crit Ultrasound J. 2013;5(Suppl 1):S11.
pubmed: 23902680 pmcid: 3711721 doi: 10.1186/2036-7902-5-S1-S11
Ralls PW, Colletti PM, Lapin SA, et al. Real-time sonography in suspected acute cholecystitis. Prospective evaluation of primary and secondary signs. Radiology. 1985;155:767–71.
pubmed: 3890007 doi: 10.1148/radiology.155.3.3890007
Martinez A, Bona X, Velasco M, et al. Diagnostic accuracy of ultrasound in acute cholecystitis. Gastrointest Radiol. 1986;11:334–8.
pubmed: 3533695 doi: 10.1007/BF02035103
Cohan RH, Mahony BS, Bowie JD, et al. Striated intramural gallbladder lucencies on US studies: predictors of acute cholecystitis. Radiology. 1987;164:31–5.
pubmed: 3295991 doi: 10.1148/radiology.164.1.3295991
Ralls PW, Halls J, Lapin SA, et al. Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis. J Clin Ultrasound. 1982;10:113–5.
pubmed: 6804512 doi: 10.1002/jcu.1870100305
Bree RL. Further observations on the usefulness of the sonographic Murphy sign in the evaluation of suspected acute cholecystitis. J Clin Ultrasound. 1995;23:169–72.
pubmed: 7730462 doi: 10.1002/jcu.1870230304
Harvey RT, Miller WT Jr. Acute biliary disease: initial CT and follow-up US versus initial US and follow-up CT. Radiology. 1999;213:831–6.
pubmed: 10580962 doi: 10.1148/radiology.213.3.r99dc17831
Mirvis SE, Vainright JR, Nelson AW, et al. The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT. AJR Am J Roentgenol. 1986;147:1171–5.
pubmed: 3535451 doi: 10.2214/ajr.147.6.1171
Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:17–30.
pubmed: 29032610 doi: 10.1002/jhbp.512
Kiriyama S, Takada T, Strasberg SM, et al. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19:548–56.
pubmed: 22825491 pmcid: 3429782 doi: 10.1007/s00534-012-0537-3
Abboud PA, Malet PF, Berlin JA, et al. Predictors of common bile duct stones prior to cholecystectomy: a meta-analysis. Gastrointest Endosc. 1996;44:450–5.
pubmed: 8905367 doi: 10.1016/S0016-5107(96)70098-6
Inui K, Fujita N. Diagnosis of choledocholithiasis. J Jpn Biliary Assoc. 2010;24:239–244 (in Japanese with English abstract)
Tseng CW, Chen CC, Chen TS, et al. Can computed tomography with coronal reconstruction improve the diagnosis of choledocholithiasis? J Gastroenterol Hepatol. 2008;23:1586–9.
pubmed: 18713297 doi: 10.1111/j.1440-1746.2008.05547.x
Mark DH, Flamm CR, Aronson N. Evidence-based assessment of diagnostic modalities for common bile duct stones. Gastrointest Endosc. 2002;56:S190–4.
pubmed: 12447266 doi: 10.1016/S0016-5107(02)70010-2
Chen W, Mo JJ, Lin L, et al. Diagnostic value of magnetic resonance cholangiopancreatography in choledocholithiasis. World J Gastroenterol. 2015;21:3351–60.
pubmed: 25805944 pmcid: 4363767 doi: 10.3748/wjg.v21.i11.3351
Jendresen MB, Thorboll JE, Adamsen S, et al. Preoperative routine magnetic resonance cholangiopancreatography before laparoscopic cholecystectomy: a prospective study. Eur J Surg. 2002;168:690–4.
pubmed: 15362577 doi: 10.1080/11024150201680024
Tse F, Liu L, Barkun AN, et al. EUS: a meta-analysis of test performance in suspected choledocholithiasis. Gastrointest Endosc. 2008;67:235–44.
pubmed: 18226685 doi: 10.1016/j.gie.2007.09.047
Gurusamy KS, Giljaca V, Takwoingi Y, et al. Endoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones. Cochrane Database Syst Rev. 2015;(2):CD011548.
Endo T, Ito K, Fujita N, et al. Intraductal ultrasonography in the diagnosis of bile duct stones: when and whom? Dig Endosc. 2011;23:173–5.
pubmed: 21429024 doi: 10.1111/j.1443-1661.2010.01071.x
Kim DC, Moon JH, Choi HJ, et al. Usefulness of intraductal ultrasonography in icteric patients with highly suspected choledocholithiasis showing normal endoscopic retrograde cholangiopancreatography. Dig Dis Sci. 2014;59:1902–8.
pubmed: 25008424 doi: 10.1007/s10620-014-3127-1
Meeralam Y, Al-Shammari K, Yaghoobi M. Diagnostic accuracy of EUS compared with MRCP in detecting choledocholithiasis: a meta-analysis of diagnostic test accuracy in head-to-head studies. Gastrointest Endosc. 2017;86:986–93.
pubmed: 28645544 doi: 10.1016/j.gie.2017.06.009
Liu CL, Lo CM, Chan JK, et al. Detection of choledocholithiasis by EUS in acute pancreatitis: a prospective evaluation in 100 consecutive patients. Gastrointest Endosc. 2001;54:325–30.
pubmed: 11522972 doi: 10.1067/mge.2001.117513
Liu CL, Fan ST, Lo CM, et al. Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol. 2005;3:1238–44.
pubmed: 16361050 doi: 10.1016/S1542-3565(05)00619-1
Petrov MS, Savides TJ. Systematic review of endoscopic ultrasonography versus endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis. Br J Surg. 2009;96:967–74.
pubmed: 19644975 doi: 10.1002/bjs.6667
Tokumura H. Development of primary bile duct stones-function of the major papilla and biliary infection. Naika. 2005;95:217–22 (in Japanese).
Hasegawa H, Sakamoto E, Komatsu S, et al. Laparoscopic management of common bile duct stones. Journal of Japan Biliary Association. 2010;24:554–560 (in Japanese with English abstract).
Ministry of Health, Labour, and Welfare. A guide to the treatment of intrahepatic stone disease. Research Group for Intractable Hepatobiliary Diseases, editor. Tokyo: Bunkodo; 2011 (in Japanese).
Mori T, Suzuki Y, Tazuma S, et al. Hepatolithiasis; 8th nationwide cross-sectional survey. Report of the research group on intractable hepato-biliary diseases. 2019:75–80 (in Japanese).
Tsuchiya S, Tsuyuguchi T, Sakai Y, et al. Lon-term follow-up of silent stones in the peripheral bile duct. Tan to Sui. 2007;28:505–8 (in Japanese).
Kudo M, Izumi N, Kubo S, et al. Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2020;50:15–46.
pubmed: 31655492 pmcid: 7003938 doi: 10.1111/hepr.13438
Sasanuma H, Sata N, Endo K, et al. Profile of intrahepatic cholangiocarcinoma associated hepatolithiasis. J Jpn Biliary Assoc. 2014;28:741–746 (in Japanese with English abstract).
Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:96–100.
pubmed: 29090868 doi: 10.1002/jhbp.519
Catena F, Ansaloni L, Bianchi E, et al. The ACTIVE (Acute Cholecystitis Trial Invasive Versus Endoscopic) Study: multicenter randomized, double-blind, controlled trial of laparoscopic versus open surgery for acute cholecystitis. Hepatogastroenterology. 2013;60:1552–6.
pubmed: 24634923
Boo YJ, Kim WB, Kim J, et al. Systemic immune response after open versus laparoscopic cholecystectomy in acute cholecystitis: a prospective randomized study. Scand J Clin Lab Invest. 2007;67:207–14.
pubmed: 17366000 doi: 10.1080/00365510601011585
Johansson M, Thune A, Nelvin L, et al. Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Br J Surg. 2005;92:44–9.
pubmed: 15584058 doi: 10.1002/bjs.4836
Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:3–16.
pubmed: 29090866 doi: 10.1002/jhbp.518
Kim EY, Yoon YC, Choi HJ, et al. Is there a real role of postoperative antibiotic administration for mildmoderate acute cholecystitis? A prospective randomized controlled trial. J Hepatobiliary Pancreat Sci. 2017;24:550–8.
pubmed: 28834296 doi: 10.1002/jhbp.495
Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.
pubmed: 7722560 doi: 10.1016/0895-4356(94)90129-5
Sakamoto T, Fujiogi M, Matsui H, et al. Timing of cholecystectomy after percutaneous transhepatic gallbladder drainage for acute cholecystitis: a nationwide inpatient database study. HPB (Oxf). 2020;22:920–6.
doi: 10.1016/j.hpb.2019.10.2438
Siddiqui A, Kunda R, Tyberg A, et al. Three-way comparative study of endoscopic ultrasound-guided transmural gallbladder drainage using lumen-apposing metal stents versus endoscopic transpapillary drainage versus percutaneous cholecystostomy for gallbladder drainage in high-risk surgical patients with acute cholecystitis: clinical outcomes and success in an International, Multicenter Study. Surg Endosc. 2019;33:1260–70.
pubmed: 30209610 doi: 10.1007/s00464-018-6406-7
Rothrock SG, Green SM, Gorton E. Atropine for the treatment of biliary tract pain: a double-blind, placebo-controlled trial. Ann Emerg Med. 1993;22:1324–7.
pubmed: 8333639 doi: 10.1016/S0196-0644(05)80118-0
Miyoshi S. Effect of trihydroxy propiophenone on subjective symptoms (especially in bile duct diseases). Naika Hokan. 1967;14:187–91 (in Japanese).
pubmed: 5624698
Goldman G, Kahn PJ, Alon R, et al. Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci. 1989;34:809–11.
pubmed: 2656133 doi: 10.1007/BF01540262
Magrini M, Rivolta G, Movilia PG, et al. Successful treatment of biliary colic with intravenous ketoprofen or lysine acetylsalicylate. Curr Med Res Opin. 1985;9:454–60.
pubmed: 3928264 doi: 10.1185/03007998509109619
Al-Waili N, Saloom KY. The analgesic effect of intravenous tenoxicam in symptomatic treatment of biliary colic: a comparison with hyoscine N-butylbromide. Eur J Med Res. 1998;3:475–9.
pubmed: 9753705
Akriviadis EA, Hatzigavriel M, Kapnias D, et al. Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study. Gastroenterology. 1997;113:225–31.
pubmed: 9207282 doi: 10.1016/S0016-5085(97)70099-4
Venneman NG, Besselink MG, Keulemans YC, et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology. 2006;43:1276–83.
pubmed: 16729326 doi: 10.1002/hep.21182
May GR, Sutherland LR, Shaffer EA. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther. 1993;7:139–48.
pubmed: 8485266 doi: 10.1111/j.1365-2036.1993.tb00082.x
Yamaguchi A, Tazuma S, Chayama K. The modality of non-surgical treatments for gallstones: factors affecting gallstone recurrence after extracorporeal shock wave lithotripsy (ESWL) and post-therapeutic symptoms. J Jpn Biliary Assoc. 2004;18:108–113 (in Japanese with English abstract).
Jain D, Bhandari BS, Agrawal N, et al. Endoscopic Ultrasound-Guided Gallbladder Drainage Using a Lumen-Apposing Metal Stent for Acute Cholecystitis: A Systematic Review. Clin Endosc. 2018;51:450–62.
pubmed: 29852730 pmcid: 6182281 doi: 10.5946/ce.2018.024
Ransohoff DF, Gracie WA. Treatment of gallstones. Ann Intern Med. 1993;119:606–19.
pubmed: 8363172 doi: 10.7326/0003-4819-119-7_Part_1-199310010-00010
Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic gallstones. Br J Surg. 2004;91:734–8.
pubmed: 15164444 doi: 10.1002/bjs.4547
Gurusamy KS, Davidson BR. Surgical treatment of gallstones. Gastroenterol Clin North Am. 2010;39:229–44, viii.
Shoda J, Kawamoto T. Gallbladder cancer and gallstone. J Jpn Biliary Assoc. 2012;26:205–211 (in Japanese with English abstract).
Fendrick AM, Gleeson SP, Cabana MD, et al. Asymptomatic gallstones revisited. Is there a role for laparoscopic cholecystectomy? Arch Fam Med. 1993;2:959–68.
pubmed: 8111527 doi: 10.1001/archfami.2.9.959
Ibrahim M, Sarvepalli S, Morris-Stiff G, et al. Gallstones: watch and wait, or intervene? Cleve Clin J Med. 2018;85:323–31.
pubmed: 29634468 doi: 10.3949/ccjm.85a.17035
Watemberg S, Rahmani H, Avrahami R, et al. Agenesis of the gallbladder found at laparoscopy for cholecystectomy: an unpleasant surprise. Am J Gastroenterol. 1995;90:1020–1.
pubmed: 7771402
Reuther G, Kiefer B, Tuchmann A. Cholangiography before biliary surgery: single-shot MR cholangiography versus intravenous cholangiography. Radiology. 1996;198:561–6.
pubmed: 8596866 doi: 10.1148/radiology.198.2.8596866
Yamashita H, Chijiiwa K, Ogawa Y, et al. The internal biliary fistula–reappraisal of incidence, type, diagnosis and management of 33 consecutive cases. HPB Surg. 1997;10:143–7.
pubmed: 9174858 pmcid: 2423849 doi: 10.1155/1997/95363
Kobari M, Ise H, Suzuki N. タイトルなし. The Biliary Tract & Pancreas. 1990;11:1317–1322 (Japanese).
Tanaka N, Nobori M, Harihara Y, et al. Surgical treatment of 45 cases of contracted gallbladder. J Japanese Practical Surg Soc. 1990;52:319–325 (in Japanese with English abstract).
Otani K, Chijiiwa K, Ohuchida J, et al. Surgical management of gallstones and gallbladder polyps with suspect of cancer. Surgery. 2009;71:29–33 (in Japanese).
Engel JM, Deitch EA, Sikkema W. Gallbladder wall thickness: sonographic accuracy and relation to disease. AJR Am J Roentgenol. 1980;134:907–9.
pubmed: 6768264 doi: 10.2214/ajr.134.5.907
Iwashita Y, Hibi T, Ohyama T, et al. Delphi consensus on bile duct injuries during laparoscopic cholecystectomy: an evolutionary cul-de-sac or the birth pangs of a new technical framework? J Hepatobiliary Pancreat Sci. 2017;24:591–602.
pubmed: 28884962 doi: 10.1002/jhbp.503
Okamoto K, Suzuki K, Takada T, et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:55–72.
pubmed: 29045062 doi: 10.1002/jhbp.516
NIH Consensus Conference. Gallstones and laparoscopic cholecystectomy. JAMA. 1993;269:1018–24.
doi: 10.1001/jama.1993.03500080066034
Academic Committee of The Japanese Society for Endoscopic Surgery. Questionnaire Survey on Endoscopic Surgery—Report on the Results of the 14th Total Survey. J Jpn Soc Endosc Surg. 2018;23:727–890 (Japanese)
Mentes BB, Akin M, Irkorucu O, et al. Gastrointestinal quality of life in patients with symptomatic or asymptomatic cholelithiasis before and after laparoscopic cholecystectomy. Surg Endosc. 2001;15:1267–72.
pubmed: 11727131 doi: 10.1007/s00464-001-9015-8
Wakabayashi G, Iwashita Y, Hibi T, et al. Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:73–86.
pubmed: 29095575 doi: 10.1002/jhbp.517
Endo I, Takada T, Hwang TL, et al. Optimal treatment strategy for acute cholecystitis based on predictive factors: Japan-Taiwan multicenter cohort study. J Hepatobiliary Pancreat Sci. 2017;24:346–61.
pubmed: 28419741 doi: 10.1002/jhbp.456
Kiviniemi H, Makela JT, Autio R, et al. Percutaneous cholecystostomy in acute cholecystitis in high-risk patients: an analysis of 69 patients. Int Surg. 1998;83:299–302.
pubmed: 10096746
Sugiyama M, Tokuhara M, Atomi Y. Is percutaneous cholecystostomy the optimal treatment for acute cholecystitis in the very elderly? World J Surg. 1998;22:459–63.
pubmed: 9564288 doi: 10.1007/s002689900416
Akhan O, Akinci D, Ozmen MN. Percutaneous cholecystostomy. Eur J Radiol. 2002;43:229–36.
pubmed: 12204405 doi: 10.1016/S0720-048X(02)00158-4
Donald JJ, Cheslyn-Curtis S, Gillams AR, et al. Percutaneous cholecystolithotomy: is gall stone recurrence inevitable? Gut. 1994;35:692–5.
pubmed: 8200568 pmcid: 1374759 doi: 10.1136/gut.35.5.692
Hultman CS, Herbst CA, McCall JM, et al. The efficacy of percutaneous cholecystostomy in critically ill patients. Am Surg. 1996;62:263–9.
pubmed: 8600844
Melin MM, Sarr MG, Bender CE, et al. Percutaneous cholecystostomy: a valuable technique in high-risk patients with presumed acute cholecystitis. Br J Surg. 1995;82:1274–7.
pubmed: 7552017 doi: 10.1002/bjs.1800820939
Davis CA, Landercasper J, Gundersen LH, et al. Effective use of percutaneous cholecystostomy in high-risk surgical patients: techniques, tube management, and results. Arch Surg. 1999;134:727–31 (discussion 731–2).
Jang JW, Lee SS, Song TJ, et al. Endoscopic ultrasound-guided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis. Gastroenterology. 2012;142:805–11.
pubmed: 22245666 doi: 10.1053/j.gastro.2011.12.051
Itoi T, Coelho-Prabhu N, Baron TH. Endoscopic gallbladder drainage for management of acute cholecystitis. Gastrointest Endosc. 2010;71:1038–45.
pubmed: 20438890 doi: 10.1016/j.gie.2010.01.026
Khan MA, Atiq O, Kubiliun N, et al. Efficacy and safety of endoscopic gallbladder drainage in acute cholecystitis: Is it better than percutaneous gallbladder drainage? Gastrointest Endosc. 2017;85(76–87): e3.
Mohan BP, Khan SR, Trakroo S, et al. Endoscopic ultrasound-guided gallbladder drainage, transpapillary drainage, or percutaneous drainage in high risk acute cholecystitis patients: a systematic review and comparative meta-analysis. Endoscopy. 2020;52:96–106.
pubmed: 31645067 doi: 10.1055/a-1020-3932
Patel IJ, Davidson JC, Nikolic B, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23:727–36.
pubmed: 22513394 doi: 10.1016/j.jvir.2012.02.012
Hamada T, Yasunaga H, Nakai Y, et al. Severe bleeding after percutaneous transhepatic drainage of the biliary system: effect of antithrombotic agents–analysis of 34 606 cases from a Japanese nationwide administrative database. Radiology. 2015;274:605–13.
pubmed: 25203133 doi: 10.1148/radiol.14140293
Kalva NR, Vanar V, Forcione D, et al. Efficacy and Safety of Lumen Apposing Self-Expandable Metal Stents for EUS Guided Cholecystostomy: A Meta-Analysis and Systematic Review. Can J Gastroenterol Hepatol. 2018;2018:7070961.
pubmed: 29850458 pmcid: 5925026 doi: 10.1155/2018/7070961
Mohan BP, Asokkumar R, Shakhatreh M, et al. Adverse events with lumen-apposing metal stents in endoscopic gallbladder drainage: a systematic review and meta-analysis. Endosc Ultrasound. 2019;8:241–8.
pubmed: 31115387 pmcid: 6714485 doi: 10.4103/eus.eus_63_18
Cui Y, Liu Y, Li Z, et al. Appraisal of diagnosis and surgical approach for Mirizzi syndrome. ANZ J Surg. 2012;82:708–13.
pubmed: 22901276 doi: 10.1111/j.1445-2197.2012.06149.x
Kulkarni SS, Hotta M, Sher L, et al. Complicated gallstone disease: diagnosis and management of Mirizzi syndrome. Surg Endosc. 2017;31:2215–22.
pubmed: 27585469 doi: 10.1007/s00464-016-5219-9
Gelbard R, Khor D, Inaba K, et al. Role of Laparoscopic Surgery in the Current Management of Mirizzi Syndrome. Am Surg. 2018;84:667–71.
pubmed: 29966566 doi: 10.1177/000313481808400517
Chen H, Siwo EA, Khu M, et al. Current trends in the management of Mirizzi Syndrome: A review of literature. Medicine (Baltimore). 2018;97: e9691.
pubmed: 29369192 doi: 10.1097/MD.0000000000009691
Beltran MA. Mirizzi syndrome: history, current knowledge and proposal of a simplified classification. World J Gastroenterol. 2012;18:4639–50.
pubmed: 23002333 pmcid: 3442202 doi: 10.3748/wjg.v18.i34.4639
Antoniou SA, Antoniou GA, Makridis C. Laparoscopic treatment of Mirizzi syndrome: a systematic review. Surg Endosc. 2010;24:33–9.
pubmed: 19466486 doi: 10.1007/s00464-009-0520-5
Shirah BH, Shirah HA, Albeladi KB. Mirizzi syndrome: necessity for safe approach in dealing with diagnostic and treatment challenges. Ann Hepatobiliary Pancreat Surg. 2017;21:122–30.
pubmed: 28989998 pmcid: 5620472 doi: 10.14701/ahbps.2017.21.3.122
Yuan H, Yuan T, Sun X, et al. A Minimally Invasive Strategy for Mirizzi Syndrome Type II: Combined Endoscopic With Laparoscopic Approach. Surg Laparosc Endosc Percutan Tech. 2016;26:248–52.
pubmed: 27077221 doi: 10.1097/SLE.0000000000000260
Mithani R, Schwesinger WH, Bingener J, et al. The Mirizzi syndrome: multidisciplinary management promotes optimal outcomes. J Gastrointest Surg. 2008;12:1022–8.
pubmed: 17874273 doi: 10.1007/s11605-007-0305-x
Sepe PS, Berzin TM, Sanaka S, et al. Single-operator cholangioscopy for the extraction of cystic duct stones (with video). Gastrointest Endosc. 2012;75:206–10.
pubmed: 22047700 doi: 10.1016/j.gie.2011.08.025
Tsuyuguchi T, Sakai Y, Sugiyama H, et al. Long-term follow-up after peroral cholangioscopy-directed lithotripsy in patients with difficult bile duct stones, including Mirizzi syndrome: an analysis of risk factors predicting stone recurrence. Surg Endosc. 2011;25:2179–85.
pubmed: 21184106 doi: 10.1007/s00464-010-1520-1
Bhandari S, Bathini R, Sharma A, et al. Usefulness of single-operator cholangioscopy-guided laser lithotripsy in patients with Mirizzi syndrome and cystic duct stones: experience at a tertiary care center. Gastrointest Endosc. 2016;84:56–61.
pubmed: 26764195 doi: 10.1016/j.gie.2015.12.025
Ryozawa S, Itoi T, Katanuma A, et al. Japan Gastroenterological Endoscopy Society guidelines for endoscopic sphincterotomy. Dig Endosc. 2018;30:149–73.
pubmed: 29247546 doi: 10.1111/den.13001
Itoi T, Ryozawa S, Katanuma A, et al. Japan Gastroenterological Endoscopy Society guidelines for endoscopic papillary large balloon dilation. Dig Endosc. 2018;30:293–309.
pubmed: 29411902 doi: 10.1111/den.13029
Yasuda I, Itoi T. Recent advances in endoscopic management of difficult bile duct stones. Dig Endosc. 2013;25:376–85.
pubmed: 23650878 doi: 10.1111/den.12118
Wandling MW, Hungness ES, Pavey ES, et al. Nationwide Assessment of Trends in Choledocholithiasis Management in the United States From 1998 to 2013. JAMA Surg. 2016;151:1125–30.
pubmed: 27556900 doi: 10.1001/jamasurg.2016.2059
Ricci C, Pagano N, Taffurelli G, et al. Comparison of Efficacy and Safety of 4 Combinations of Laparoscopic and Intraoperative Techniques for Management of Gallstone Disease With Biliary Duct Calculi: A Systematic Review and Network Meta-analysis. JAMA Surg. 2018;153: e181167.
pubmed: 29847616 pmcid: 6137518 doi: 10.1001/jamasurg.2018.1167
Xu J, Yang C. Cholecystectomy outcomes after endoscopic sphincterotomy in patients with choledocholithiasis: a meta-analysis. BMC Gastroenterol. 2020;20:229.
pubmed: 32680467 pmcid: 7367327 doi: 10.1186/s12876-020-01376-y
Bove A, Di Renzo RM, Palone G, et al. Single-stage procedure for the treatment of cholecysto-choledocolithiasis: a surgical procedures review. Ther Clin Risk Manag. 2018;14:305–12.
pubmed: 29503549 pmcid: 5824758 doi: 10.2147/TCRM.S146461
De Palma GD. Minimally invasive treatment of cholecysto-choledocal lithiasis: The point of view of the surgical endoscopist. World J Gastrointest Surg. 2013;5:161–6.
pubmed: 23977417 pmcid: 3750126 doi: 10.4240/wjgs.v5.i6.161
Enochsson L, Lindberg B, Swahn F, et al. Intraoperative endoscopic retrograde cholangiopancreatography (ERCP) to remove common bile duct stones during routine laparoscopic cholecystectomy does not prolong hospitalization: a 2-year experience. Surg Endosc. 2004;18:367–71.
pubmed: 14752630 doi: 10.1007/s00464-003-9021-0
Liverani A, Muroni M, Santi F, et al. One-step laparoscopic and endoscopic treatment of gallbladder and common bile duct stones: our experience of the last 9 years in a retrospective study. Am Surg. 2013;79:1243–7.
pubmed: 24351349 doi: 10.1177/000313481307901213
Lyu Y, Cheng Y, Li T, et al. Laparoscopic common bile duct exploration plus cholecystectomy versus endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy for cholecystocholedocholithiasis: a meta-analysis. Surg Endosc. 2019;33:3275–86.
pubmed: 30511313 doi: 10.1007/s00464-018-06613-w
Schreurs WH, Vles WJ, Stuifbergen WH, et al. Endoscopic management of common bile duct stones leaving the gallbladder in situ. A cohort study with long-term follow-up. Dig Surg. 2004;21:60–4 (discussion 65).
Boerma D, Rauws EA, Keulemans YC, et al. Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial. Lancet. 2002;360:761–5.
pubmed: 12241833 doi: 10.1016/S0140-6736(02)09896-3
Dasari BV, Tan CJ, Gurusamy KS, et al. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev. 2013;2013:CD003327.
Singh AN, Kilambi R. Single-stage laparoscopic common bile duct exploration and cholecystectomy versus two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with gallbladder stones with common bile duct stones: systematic review and meta-analysis of randomized trials with trial sequential analysis. Surg Endosc. 2018;32:3763–76.
pubmed: 29603004 doi: 10.1007/s00464-018-6170-8
Bansal VK, Misra MC, Rajan K, et al. Single-stage laparoscopic common bile duct exploration and cholecystectomy versus two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with concomitant gallbladder stones and common bile duct stones: a randomized controlled trial. Surg Endosc. 2014;28:875–85.
pubmed: 24162138 doi: 10.1007/s00464-013-3237-4
Topal B, Vromman K, Aerts R, et al. Hospital cost categories of one-stage versus two-stage management of common bile duct stones. Surg Endosc. 2010;24:413–6.
pubmed: 19554369 doi: 10.1007/s00464-009-0594-0
Rogers SJ, Cello JP, Horn JK, et al. Prospective randomized trial of LC+LCBDE vs ERCP/S+LC for common bile duct stone disease. Arch Surg. 2010;145:28–33.
pubmed: 20083751 doi: 10.1001/archsurg.2009.226
Tokumura H, Matsumura N, Musha H, et al. Recurrence of Common bile duct stones after surgical stone removal with preservation of papillary function. Tan to Sui. 2010;31:305–8 (in Japanese).
Doi S, Yasuda I, Mabuchi M, et al. Long term outcome after EST and EPBD for bile duct stones with gallbladder stones. Tan to Sui. 2014;35:1365–1369 (in Japanese)
Hasegawa H, Yamamoto H, Ymamoto R, et al. Results of the laparoscopic management of common bile duct stones –Significance of preservation of sphincter function. Tan to Sui. 2014;35:1339–43 (in Japanese).
Yoshikawa J, Matsumoto J. Evaluation of endoscopic sphincter of Oddi manometry in patients with biliary diseases. J Jpn Biliary Assoc. 2003;17:396–401 (in Japanese with English abstract)
Naito T, Hata T, Iseki M, et al. Manometric study of the bile duct. Tan to Sui. 2019;40:203–6 (in Japanese).
Aoki Y, Tanimura H, Kawashima H, et al. Cholescintigraphic observation of the sphincter of Oddi motor activity in patients with gallstone. Nihon Geka Hokan. 1989;58:289–98.
pubmed: 2619434
Takehara Y. Assessment of sphincter of Oddi dysfunction with pharmaco-dynamic (functional) MRCP. Tan to Sui. 2008;29:813–22 (in Japanese).
Grubnik VV, Tkachenko AI, Ilyashenko VV, et al. Laparoscopic common bile duct exploration versus open surgery: comparative prospective randomized trial. Surg Endosc. 2012;26:2165–71.
pubmed: 22350244 doi: 10.1007/s00464-012-2194-7
Wang X, Dai C, Jiang Z, et al. Endoscopic retrograde cholangiopancreatography versus laparoscopic exploration for common bile duct stones in post-cholecystectomy patients: a retrospective study. Oncotarget. 2017;8:82114–22.
pubmed: 29137249 pmcid: 5669875 doi: 10.18632/oncotarget.18839
Johnson AG, Hosking SW. Appraisal of the management of bile duct stones. Br J Surg. 1987;74:555–60.
pubmed: 3304517 doi: 10.1002/bjs.1800740703
Joyce WP, Keane R, Burke GJ, et al. Identification of bile duct stones in patients undergoing laparoscopic cholecystectomy. Br J Surg. 1991;78:1174–6.
pubmed: 1835665 doi: 10.1002/bjs.1800781008
Sarli L, Costi R, Gobbi S, et al. Asymptomatic bile duct stones: selection criteria for intravenous cholangiography and/or endoscopic retrograde cholangiography prior to laparoscopic cholecystectomy. Eur J Gastroenterol Hepatol. 2000;12:1175–80.
pubmed: 11111772 doi: 10.1097/00042737-200012110-00002
Horwood J, Akbar F, Davis K, et al. Prospective evaluation of a selective approach to cholangiography for suspected common bile duct stones. Ann R Coll Surg Engl. 2010;92:206–10.
pubmed: 20223077 pmcid: 3080093 doi: 10.1308/003588410X12628812458293
Kim SB, Kim KH, Kim TN. Comparison of Outcomes and Complications of Endoscopic Common Bile Duct Stone Removal Between Asymptomatic and Symptomatic Patients. Dig Dis Sci. 2016;61:1172–7.
pubmed: 26589817 doi: 10.1007/s10620-015-3965-5
Hakuta R, Hamada T, Nakai Y, et al. Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes. J Gastroenterol. 2020;55:78–85.
pubmed: 31473828 doi: 10.1007/s00535-019-01612-7
Itoi T, Tsuyuguchi T, Takada T, et al. TG13 indications and techniques for biliary drainage in acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2013;20:71–80.
pubmed: 23307008 doi: 10.1007/s00534-012-0569-8
Lee JK, Lee SH, Kang BK, et al. Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? A prospective, randomized trial. Gastrointest Endosc. 2010;71:105–10.
pubmed: 19913785 doi: 10.1016/j.gie.2009.08.009
Ueki T, Otani K, Fujimura N, et al. Comparison between emergency and elective endoscopic sphincterotomy in patients with acute cholangitis due to choledocholithiasis: is emergency endoscopic sphincterotomy safe? J Gastroenterol. 2009;44:1080–8.
pubmed: 19597758 doi: 10.1007/s00535-009-0100-4
Eto K, Kawakami H, Haba S, et al. Single-stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis: a multicenter, non-randomized, open-label and exploratory clinical trial. J Hepatobiliary Pancreat Sci. 2015;22:825–30.
pubmed: 26510180 doi: 10.1002/jhbp.296
Ayub K, Imada R, Slavin J. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitis. Cochrane Database Syst Rev. 2004;(4):CD003630. https://doi.org/10.1002/14651858.CD003630.pub2 .
Petrov MS, van Santvoort HC, Besselink MG, et al. Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials. Ann Surg. 2008;247:250–7.
pubmed: 18216529 doi: 10.1097/SLA.0b013e31815edddd
Uy MC, Daez ML, Sy PP, et al. Early ERCP in acute gallstone pancreatitis without cholangitis: a meta-analysis. JOP. 2009;10:299–305.
pubmed: 19454823
Tse F, Yuan Y. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitis. Cochrane Database Syst Rev. 2012;(5):CD009779.
Burstow MJ, Yunus RM, Hossain MB, et al. Meta-Analysis of Early Endoscopic Retrograde Cholangiopancreatography (ERCP) +/- Endoscopic Sphincterotomy (ES) Versus Conservative Management for Gallstone Pancreatitis (GSP). Surg Laparosc Endosc Percutan Tech. 2015;25:185–203.
pubmed: 25799261 doi: 10.1097/SLE.0000000000000142
Ersoz G, Tekesin O, Ozutemiz AO, et al. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc. 2003;57:156–9.
pubmed: 12556775 doi: 10.1067/mge.2003.52
Kim TH, Kim JH, Seo DW, et al. International consensus guidelines for endoscopic papillary large-balloon dilation. Gastrointest Endosc. 2016;83:37–47.
pubmed: 26232360 doi: 10.1016/j.gie.2015.06.016
Feng Y, Zhu H, Chen X, et al. Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials. J Gastroenterol. 2012;47:655–63.
pubmed: 22361862 doi: 10.1007/s00535-012-0528-9
Liu Y, Su P, Lin Y, et al. Endoscopic sphincterotomy plus balloon dilation versus endoscopic sphincterotomy for choledocholithiasis: A meta-analysis. J Gastroenterol Hepatol. 2013;28:937–45.
pubmed: 23489041 doi: 10.1111/jgh.12192
Yang XM, Hu B. Endoscopic sphincterotomy plus large-balloon dilation vs endoscopic sphincterotomy for choledocholithiasis: a meta-analysis. World J Gastroenterol. 2013;19:9453–60.
pubmed: 24409076 pmcid: 3882422 doi: 10.3748/wjg.v19.i48.9453
Jin PP, Cheng JF, Liu D, et al. Endoscopic papillary large balloon dilation vs endoscopic sphincterotomy for retrieval of common bile duct stones: a meta-analysis. World J Gastroenterol. 2014;20:5548–56.
pubmed: 24833886 pmcid: 4017071 doi: 10.3748/wjg.v20.i18.5548
Dong SQ, Singh TP, Zhao Q, et al. Sphincterotomy plus balloon dilation versus sphincterotomy alone for choledocholithiasis: a meta-analysis. Endoscopy. 2019;51:763–71.
pubmed: 30786316 doi: 10.1055/a-0848-8271
Liu P, Lin H, Chen Y, et al. Comparison of endoscopic papillary large balloon dilation with and without a prior endoscopic sphincterotomy for the treatment of patients with large and/or multiple common bile duct stones: a systematic review and meta-analysis. Ther Clin Risk Manag. 2019;15:91–101.
pubmed: 30666119 pmcid: 6331186 doi: 10.2147/TCRM.S182615
Kim KH, Rhu JH, Kim TN. Recurrence of bile duct stones after endoscopic papillary large balloon dilation combined with limited sphincterotomy: long-term follow-up study. Gut Liver. 2012;6:107–12.
pubmed: 22375179 pmcid: 3286727 doi: 10.5009/gnl.2012.6.1.107
Maruta A, Iwashita T, Uemura S, et al. Comparison of late adverse events after endoscopic sphincterotomy versus endoscopic papillary large balloon dilation for common bile duct stones: A propensity score-based cohort analysis. Dig Endosc. 2018;30:493–500.
pubmed: 29399885 doi: 10.1111/den.13031
Miyoshi H, Inui K, Yamamoto S, et al. Extracorporeal Shock Wave Lithotripsy for Bile Duct Stones. Clin Gastroenterol. 2017;32:57–61 (in Japanese with English abstract)
Jin Z, Wei Y, Tang X, et al. Single-operator peroral cholangioscope in treating difficult biliary stones: A systematic review and meta-analysis. Dig Endosc. 2019;31:256–69.
pubmed: 30468534 doi: 10.1111/den.13307
Yasuda I. Recent advances in endoscopic management of difficult bile duct stones. Nihon Shokakibyo Gakkai Zasshi. 2016;113:585–93 (in Japanese).
pubmed: 27052388
Gad EH, Zakaria H, Kamel Y, et al. Surgical (Open and laparoscopic) management of large difficult CBD stones after different sessions of endoscopic failure: A retrospective cohort study. Ann Med Surg (Lond). 2019;43:52–63.
pubmed: 31198552 doi: 10.1016/j.amsu.2019.05.007
Lee JH, Kim HW, Kang DH, et al. Usefulness of percutaneous transhepatic cholangioscopic lithotomy for removal of difficult common bile duct stones. Clin Endosc. 2013;46:65–70.
pubmed: 23423471 pmcid: 3572354 doi: 10.5946/ce.2013.46.1.65
Jeong EJ, Kang DH, Kim DU, et al. Percutaneous transhepatic choledochoscopic lithotomy as a rescue therapy for removal of bile duct stones in Billroth II gastrectomy patients who are difficult to perform ERCP. Eur J Gastroenterol Hepatol. 2009;21:1358–62.
pubmed: 19282768 doi: 10.1097/MEG.0b013e328326caa1
Thon HJ, Loffler A, Buess G, et al. Is ERCP a reasonable diagnostic method for excluding pancreatic and hepatobiliary disease in patients with a Billroth II resection? Endoscopy. 1983;15:93–5.
pubmed: 6872970 doi: 10.1055/s-2007-1021476
Forbes A, Cotton PB. ERCP and sphincterotomy after Billroth II gastrectomy. Gut. 1984;25:971–4.
pubmed: 6469083 pmcid: 1432487 doi: 10.1136/gut.25.9.971
Osnes M, Rosseland AR, Aabakken L. Endoscopic retrograde cholangiography and endoscopic papillotomy in patients with a previous Billroth-II resection. Gut. 1986;27:1193–8.
pubmed: 3781333 pmcid: 1433853 doi: 10.1136/gut.27.10.1193
Nakahara K, Horaguchi J, Fujita N, et al. Therapeutic endoscopic retrograde cholangiopancreatography using an anterior oblique-viewing endoscope for bile duct stones in patients with prior Billroth II gastrectomy. J Gastroenterol. 2009;44:212–7.
pubmed: 19214665 doi: 10.1007/s00535-008-2299-x
Choi CW, Choi JS, Kang DH, et al. Endoscopic papillary large balloon dilation in Billroth II gastrectomy patients with bile duct stones. J Gastroenterol Hepatol. 2012;27:256–60.
pubmed: 21793902 doi: 10.1111/j.1440-1746.2011.06863.x
Shimatani M, Hatanaka H, Kogure H, et al. Diagnostic and Therapeutic Endoscopic Retrograde Cholangiography Using a Short-Type Double-Balloon Endoscope in Patients With Altered Gastrointestinal Anatomy: A Multicenter Prospective Study in Japan. Am J Gastroenterol. 2016;111:1750–8.
pubmed: 27670601 doi: 10.1038/ajg.2016.420
Yane K, Katanuma A, Maguchi H, et al. Short-type single-balloon enteroscope-assisted ERCP in postsurgical altered anatomy: potential factors affecting procedural failure. Endoscopy. 2017;49:69–74.
pubmed: 27760436
Itoi T, Ishii K, Sofuni A, et al. Long- and short-type double-balloon enteroscopy-assisted therapeutic ERCP for intact papilla in patients with a Roux-en-Y anastomosis. Surg Endosc. 2011;25:713–21.
pubmed: 20976503 doi: 10.1007/s00464-010-1226-4
Ishii K, Itoi T, Tonozuka R, et al. Balloon enteroscopy-assisted ERCP in patients with Roux-en-Y gastrectomy and intact papillae (with videos). Gastrointest Endosc. 2016;83(377–86): e6.
De Koning M, Moreels TG. Comparison of double-balloon and single-balloon enteroscope for therapeutic endoscopic retrograde cholangiography after Roux-en-Y small bowel surgery. BMC Gastroenterol. 2016;16:98.
pubmed: 27549034 pmcid: 4994384 doi: 10.1186/s12876-016-0512-6
Yamauchi H, Kida M, Okuwaki K, et al. Therapeutic peroral direct cholangioscopy using a single balloon enteroscope in patients with Roux-en-Y anastomosis (with videos). Surg Endosc. 2018;32:498–506.
pubmed: 28733743 doi: 10.1007/s00464-017-5742-3
Itoi T, Ishii K, Itokawa F, et al. Large balloon papillary dilation for removal of bile duct stones in patients who have undergone a billroth ii gastrectomy. Dig Endosc. 2010;22(Suppl 1):S98–102.
pubmed: 20590782 doi: 10.1111/j.1443-1661.2010.00955.x
Kim GH, Kang DH, Song GA, et al. Endoscopic removal of bile-duct stones by using a rotatable papillotome and a large-balloon dilator in patients with a Billroth II gastrectomy (with video). Gastrointest Endosc. 2008;67:1134–8.
pubmed: 18407269 doi: 10.1016/j.gie.2007.12.016
Itoi T, Sofuni A, Tsuchiya T, et al. Endoscopic ultrasonography-guided transhepatic antegrade stone removal in patients with surgically altered anatomy: case series and technical review (with videos). J Hepatobiliary Pancreat Sci. 2014;21:E86-93.
pubmed: 25231935 doi: 10.1002/jhbp.165
Iwashita T, Nakai Y, Hara K, et al. Endoscopic ultrasound-guided antegrade treatment of bile duct stone in patients with surgically altered anatomy: a multicenter retrospective cohort study. J Hepatobiliary Pancreat Sci. 2016;23:227–33.
pubmed: 26849099 doi: 10.1002/jhbp.329
Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25:31–40.
pubmed: 28941329 doi: 10.1002/jhbp.509
Sharaiha RZ, Khan MA, Kamal F, et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85:904–14.
pubmed: 28063840 doi: 10.1016/j.gie.2016.12.023
Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol. 2004;99:1455–60.
pubmed: 15307859 doi: 10.1111/j.1572-0241.2004.30151.x
Weinberg BM, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev. 2006;2006:CD004890.
pubmed: 17054222 pmcid: 8855932
Liu Y, Su P, Lin S, et al. Endoscopic papillary balloon dilatation versus endoscopic sphincterotomy in the treatment for choledocholithiasis: a meta-analysis. J Gastroenterol Hepatol. 2012;27:464–71.
pubmed: 21913984 doi: 10.1111/j.1440-1746.2011.06912.x
Zhao HC, He L, Zhou DC, et al. Meta-analysis comparison of endoscopic papillary balloon dilatation and endoscopic sphincteropapillotomy. World J Gastroenterol. 2013;19:3883–91.
pubmed: 23840129 pmcid: 3699051 doi: 10.3748/wjg.v19.i24.3883
Takahara N, Isayama H, Sasaki T, et al. Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis. J Gastroenterol. 2012;47:918–23.
pubmed: 22354661 doi: 10.1007/s00535-012-0551-x
Kawabe T, Komatsu Y, Tada M, et al. Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy. Endoscopy. 1996;28:694–8.
pubmed: 8934088 doi: 10.1055/s-2007-1005579
Hung TH, Tseng CW, Chen YC, et al. Endoscopic papillary balloon dilation decreases the risk of bleeding in cirrhotic patients compared with endoscopic biliary sphincterotomy: A national population-based study. Medicine (Baltimore). 2019;98: e16529.
pubmed: 31348269 doi: 10.1097/MD.0000000000016529
Choi D, Lim HK, Kim MJ, et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol. 2005;184:1860–7.
pubmed: 15908543 doi: 10.2214/ajr.184.6.01841860
Yasuda I, Fujita N, Maguchi H, et al. Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones. Gastrointest Endosc. 2010;72:1185–91.
pubmed: 20869711 doi: 10.1016/j.gie.2010.07.006
Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014;26:1–14.
pubmed: 24215155 doi: 10.1111/den.12183
Kato M, Uedo N, Hokimoto S, et al. Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants. Dig Endosc. 2018;30:433–40.
pubmed: 29733468 doi: 10.1111/den.13184
Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 2017;24:537–49.
pubmed: 28834389 doi: 10.1002/jhbp.496
Slattery E, Kale V, Anwar W, et al. Role of long-term biliary stenting in choledocholithiasis. Dig Endosc. 2013;25:440–3.
pubmed: 23808949 doi: 10.1111/j.1443-1661.2012.01399.x
Chopra KB, Peters RA, O’Toole PA, et al. Randomised study of endoscopic biliary endoprosthesis versus duct clearance for bileduct stones in high-risk patients. Lancet. 1996;348:791–3.
pubmed: 8813987 doi: 10.1016/S0140-6736(96)06316-7
Akazawa Y, Ohtani M, Nosaka T, et al. Long-term prognosis after biliary stenting for common bile duct stones in high-risk elderly patients. J Dig Dis. 2018;19:626–34.
pubmed: 30117280 doi: 10.1111/1751-2980.12656
Seitz U, Bapaye A, Bohnacker S, et al. Advances in therapeutic endoscopic treatment of common bile duct stones. World J Surg. 1998;22:1133–44.
pubmed: 9828721 doi: 10.1007/s002689900532
Itoi T, Wang HP. Endoscopic management of bile duct stones. Dig Endosc. 2010;22(Suppl 1):S69-75.
pubmed: 20590776 doi: 10.1111/j.1443-1661.2010.00953.x
ASoP Committee, Maple JT, Ikenberry SO, et al. The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc. 2011;74:731–44.
doi: 10.1016/j.gie.2011.04.012
Ishiwatari H, Kawakami H, Hisai H, et al. Balloon catheter versus basket catheter for endoscopic bile duct stone extraction: a multicenter randomized trial. Endoscopy. 2016;48:350–7.
pubmed: 26760604 doi: 10.1055/s-0035-1569573
Ozawa N, Yasuda I, Doi S, et al. Prospective randomized study of endoscopic biliary stone extraction using either a basket or a balloon catheter: the BasketBall study. J Gastroenterol. 2017;52:623–630.
Manes G, Paspatis G, Aabakken L, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019;51:472–91.
pubmed: 30943551 doi: 10.1055/a-0862-0346
Hammarstrom LE, Holmin T, Stridbeck H, et al. Long-term follow-up of a prospective randomized study of endoscopic versus surgical treatment of bile duct calculi in patients with gallbladder in situ. Br J Surg. 1995;82:1516–21.
pubmed: 8535807 doi: 10.1002/bjs.1800821121
Targarona EM, Ayuso RM, Bordas JM, et al. Randomised trial of endoscopic sphincterotomy with gallbladder left in situ versus open surgery for common bileduct calculi in high-risk patients. Lancet. 1996;347:926–9.
pubmed: 8598755 doi: 10.1016/S0140-6736(96)91413-0
Suc B, Escat J, Cherqui D, et al. Surgery vs endoscopy as primary treatment in symptomatic patients with suspected common bile duct stones: a multicenter randomized trial. French Associations for Surgical Research. Arch Surg. 1998;133:702–8.
pubmed: 9687996 doi: 10.1001/archsurg.133.7.702
Lau JY, Leow CK, Fung TM, et al. Cholecystectomy or gallbladder in situ after endoscopic sphincterotomy and bile duct stone removal in Chinese patients. Gastroenterology. 2006;130:96–103.
pubmed: 16401473 doi: 10.1053/j.gastro.2005.10.015
McAlister VC, Davenport E, Renouf E. Cholecystectomy deferral in patients with endoscopic sphincterotomy. Cochrane Database Syst Rev. 2007;2007:CD006233.
pubmed: 17943900 pmcid: 8923260
Park BK, Seo JH, Jeon HH, et al. A nationwide population-based study of common bile duct stone recurrence after endoscopic stone removal in Korea. J Gastroenterol. 2018;53:670–8.
pubmed: 29192348 doi: 10.1007/s00535-017-1419-x
Cui ML, Cho JH, Kim TN. Long-term follow-up study of gallbladder in situ after endoscopic common duct stone removal in Korean patients. Surg Endosc. 2013;27:1711–6.
pubmed: 23242488 doi: 10.1007/s00464-012-2662-0
Suzuki Y, Mori T, Yokoyama M, et al. Effect of UDCA for bile duct stone recurrence and development of cholangiocarcinoma. KanTanSui. 2018;77:77–9 (in Japanese).
Yamamoto R, Tazuma S, Kanno K, et al. Ursodeoxycholic acid after bile duct stone removal and risk factors for recurrence: a randomized trial. J Hepatobiliary Pancreat Sci. 2016;23:132–6.
pubmed: 26705893 doi: 10.1002/jhbp.316
Akiyama S, Imamura T, Tamura T, et al. Recurrent common bile duct stones composed of ursodeoxycholic acid: a report of four cases. Intern Med. 2014;53:2489–92.
pubmed: 25366008 doi: 10.2169/internalmedicine.53.2886
Nakagawara H, Yamao K, Nomura S, et al. A case of common bile duct stones composed of ursodeoxycholic acid associated with hereditary spherocytosis. J Jpn Biliary Assoc. 2017;31:279–283 (in Japanese with English abstract).
Lin CC, Lin PY, Ko CJ, et al. Hepatic resection for bilateral hepatolithiasis: a 20-year experience. ANZ J Surg. 2013;83:978–84.
pubmed: 23013139 doi: 10.1111/j.1445-2197.2012.06283.x
Yang T, Lau WY, Lai EC, et al. Hepatectomy for bilateral primary hepatolithiasis: a cohort study. Ann Surg. 2010;251:84–90.
pubmed: 20032719 doi: 10.1097/SLA.0b013e3181b2f374
Kusano T, Isa T, Ohtsubo M, et al. Natural progression of untreated hepatolithiasis that shows no clinical signs at its initial presentation. J Clin Gastroenterol. 2001;33:114–7.
pubmed: 11468436 doi: 10.1097/00004836-200108000-00004
Kim KH, Sung CK, Park BG, et al. Clinical significance of intrahepatic biliary stricture in efficacy of hepatic resection for intrahepatic stones. J Hepatobiliary Pancreat Surg. 1998;5:303–8.
pubmed: 9880779 doi: 10.1007/s005340050050
Adamek HE, Schneider AR, Adamek MU, et al. Treatment of difficult intrahepatic stones by using extracorporeal and intracorporeal lithotripsy techniques: 10 years’ experience in 55 patients. Scand J Gastroenterol. 1999;34:1157–61.
pubmed: 10582769 doi: 10.1080/003655299750024986
Hochberger J, Tex S, Maiss J, et al. Management of difficult common bile duct stones. Gastrointest Endosc Clin N Am. 2003;13:623–34.
pubmed: 14986790 doi: 10.1016/S1052-5157(03)00102-8
Amplatz S, Piazzi L, Felder M, et al. Extracorporeal shock wave lithotripsy for clearance of refractory bile duct stones. Dig Liver Dis. 2007;39:267–72.
pubmed: 17275426 doi: 10.1016/j.dld.2006.11.003
Ellis RD, Jenkins AP, Thompson RP, et al. Clearance of refractory bile duct stones with extracorporeal shockwave lithotripsy. Gut. 2000;47:728–31.
pubmed: 11034593 pmcid: 1728118 doi: 10.1136/gut.47.5.728
Muratori R, Brambati M, Rossi A, et al. Extracorporeal lithotripsy of intrahepatic stones with associated strictures of intrahepatic biliary ducts. Ital J Gastroenterol Hepatol. 1998;30:624–30.
pubmed: 10076787
Kim MH, Lee SK, Min YI, et al. Extracorporeal shockwave lithotripsy of primary intrahepatic stones. Korean J Intern Med. 1992;7:25–30.
pubmed: 1477027 pmcid: 4532094 doi: 10.3904/kjim.1992.7.1.25
Honjo M, Itoi T, Sofuni A, et al. Nonsurgical treatment for hepatolithiasis. Tan to Sui. 2013;34:1175–82 (in Japanese).
Han JK, Choi BI, Park JH, et al. Percutaneous removal of retained intrahepatic stones with a pre-shaped angulated catheter: review of 96 patients. Br J Radiol. 1992;65:9–13.
pubmed: 1486378 doi: 10.1259/0007-1285-65-769-9
Miyoshi H, Inui K, Katano Y, et al. Percutaneous transhepatic management for postoperative anastomotic segment biliary stenosis, cholangitis and intrahepatic stones. Tan to Sui. 2018;39:395–401 (in Japanese).
Oh HC, Lee SK, Lee TY, et al. Analysis of percutaneous transhepatic cholangioscopy-related complications and the risk factors for those complications. Endoscopy. 2007;39:731–6.
pubmed: 17661249 doi: 10.1055/s-2007-966577
Furuta T, Kato M, Ito T, et al. 6th report of endoscopic complications: Results of theJapan Gastroenterological Endoscopy Sociery Survey from 2008 to 2012. Gastroenterological Endoscopy. 2016;58:1466–1491 (in Japanese with English abstract).
Lamberts MP, Den Oudsten BL, Gerritsen JJ, et al. Prospective multicentre cohort study of patient-reported outcomes after cholecystectomy for uncomplicated symptomatic cholecystolithiasis. Br J Surg. 2015;102:1402–9.
pubmed: 26201942 doi: 10.1002/bjs.9887
Wennmacker SZ, Dijkgraaf MGW, Westert GP, et al. Persistent abdominal pain after laparoscopic cholecystectomy is associated with increased healthcare consumption and sick leave. Surgery. 2018;163:661–6.
pubmed: 29133112 doi: 10.1016/j.surg.2017.09.004
Latenstein CSS, Wennmacker SZ, de Jong JJ, et al. Etiologies of long-term postcholecystectomy symptoms: a systematic review. Gastroenterol Res Pract. 2019;2019:4278373.
pubmed: 31110517 pmcid: 6487117 doi: 10.1155/2019/4278373
Sauter GH, Moussavian AC, Meyer G, et al. Bowel habits and bile acid malabsorption in the months after cholecystectomy. Am J Gastroenterol. 2002;97:1732–5.
pubmed: 12135027 doi: 10.1111/j.1572-0241.2002.05779.x
Fort JM, Azpiroz F, Casellas F, et al. Bowel habit after cholecystectomy: physiological changes and clinical implications. Gastroenterology. 1996;111:617–22.
pubmed: 8780565 doi: 10.1053/gast.1996.v111.pm8780565
Arlow FL, Dekovich AA, Priest RJ, et al. Bile acid-mediated postcholecystectomy diarrhea. Arch Intern Med. 1987;147:1327–9.
pubmed: 3606289 doi: 10.1001/archinte.1987.00370070139021
Fromm H, Tunuguntla AK, Malavolti M, et al. Absence of significant role of bile acids in diarrhea of a heterogeneous group of postcholecystectomy patients. Dig Dis Sci. 1987;32:33–44.
pubmed: 3792181 doi: 10.1007/BF01296685
Sciarretta G, Furno A, Mazzoni M, et al. Post-cholecystectomy diarrhea: evidence of bile acid malabsorption assessed by SeHCAT test. Am J Gastroenterol. 1992;87:1852–4.
pubmed: 1449156
Suhr O, Danielsson A, Nyhlin H, et al. Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol. 1988;23:1187–94.
pubmed: 3249916 doi: 10.3109/00365528809090189
Porr PJ, Szantay J, Rusu M. Post-cholecystectomy syndrome and magnesium deficiency. J Am Coll Nutr. 2004;23:745S-S747.
pubmed: 15637226 doi: 10.1080/07315724.2004.10719420
Schreurs WH, Juttmann JR, Stuifbergen WN, et al. Management of common bile duct stones: selective endoscopic retrograde cholangiography and endoscopic sphincterotomy: short- and long-term results. Surg Endosc. 2002;16:1068–72.
pubmed: 11984690 doi: 10.1007/s00464-001-9104-8
Sugiyama M, Atomi Y. Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: long-term (more than 10 years) follow-up study. Am J Gastroenterol. 2002;97:2763–7.
pubmed: 12425545 doi: 10.1111/j.1572-0241.2002.07019.x
Ohashi A, Ueno N, Tamada K, et al. Assessment of residual bile duct stones with use of intraductal US during endoscopic balloon sphincteroplasty: comparison with balloon cholangiography. Gastrointest Endosc. 1999;49:328–33.
pubmed: 10049416 doi: 10.1016/S0016-5107(99)70009-X
Hammarstrom LE, Stridbeck H, Ihse I. Long-term follow-up after endoscopic treatment of bile duct calculi in cholecystectomized patients. World J Surg. 1996;20:272–6.
pubmed: 8661830 doi: 10.1007/s002689900043
Kageoka M, Watanabe F, Maruyama Y, et al. Long-term prognosis of patients after endoscopic sphincterotomy for choledocholithiasis. Dig Endosc. 2009;21:170–5.
pubmed: 19691764 doi: 10.1111/j.1443-1661.2009.00880.x
Tsujino T, Kawabe T, Isayama H, et al. Management of late biliary complications in patients with gallbladder stones in situ after endoscopic papillary balloon dilation. Eur J Gastroenterol Hepatol. 2009;21:376–80.
pubmed: 20611007 doi: 10.1097/MEG.0b013e328317f4a0
Fujimoto T, Tsuyuguchi T, Sakai Y, et al. Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Dig Endosc. 2010;22:95–100.
pubmed: 20447201 doi: 10.1111/j.1443-1661.2010.00936.x
Kogure H, Tsujino T, Isayama H, et al. Short- and long-term outcomes of endoscopic papillary large balloon dilation with or without sphincterotomy for removal of large bile duct stones. Scand J Gastroenterol. 2014;49:121–8.
pubmed: 24164293 doi: 10.3109/00365521.2013.848470
Chan HH, Lai KH, Lin CK, et al. Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones. BMC Gastroenterol. 2011;11:69.
pubmed: 21668994 pmcid: 3142528 doi: 10.1186/1471-230X-11-69
Kim KY, Han J, Kim HG, et al. Late Complications and Stone Recurrence Rates after Bile Duct Stone Removal by Endoscopic Sphincterotomy and Large Balloon Dilation are Similar to Those after Endoscopic Sphincterotomy Alone. Clin Endosc. 2013;46:637–42.
pubmed: 24340257 pmcid: 3856265 doi: 10.5946/ce.2013.46.6.637
Paspatis GA, Paraskeva K, Vardas E, et al. Long-term recurrence of bile duct stones after endoscopic papillary large balloon dilation with sphincterotomy: 4-year extended follow-up of a randomized trial. Surg Endosc. 2017;31:650–5.
pubmed: 27317037 doi: 10.1007/s00464-016-5012-9
Jeong S, Ki SH, Lee DH, et al. Endoscopic large-balloon sphincteroplasty without preceding sphincterotomy for the removal of large bile duct stones: a preliminary study. Gastrointest Endosc. 2009;70:915–22.
pubmed: 19647241 doi: 10.1016/j.gie.2009.04.042
Tanaka M, Takahata S, Konomi H, et al. Long-term consequence of endoscopic sphincterotomy for bile duct stones. Gastrointest Endosc. 1998;48:465–9.
pubmed: 9831833 doi: 10.1016/S0016-5107(98)70086-0
Tanaka M, Ogawa Y, Naritomi G, et al. Clinical significance of endoscopic sphincterotomy compared with surgical common bile duct exploration and surgical sphincterotomy. J Jpn Surg Soc. 1992;93:1119–22 (in Japanese with English abstract).
Paganini AM, Guerrieri M, Sarnari J, et al. Thirteen years’ experience with laparoscopic transcystic common bile duct exploration for stones. Effectiveness and long-term results. Surg Endosc. 2007;21:34–40.
pubmed: 17111284 doi: 10.1007/s00464-005-0286-3
Tokumura H, Matsumura N, Nomura R. Laparoscopic management of common bile duct stones. J Jpn Biliary Assoc. 2012;26:40–45 (in Japanese with English abstract).
Uchiyama K, Onishi H, Tani M, et al. Long-term prognosis after treatment of patients with choledocholithiasis. Ann Surg. 2003;238:97–102.
pubmed: 12832971 pmcid: 1422666 doi: 10.1097/01.sla.0000077923.38307.84
Natsui M, Saito Y, Abe S, et al. Long-term outcomes of endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones. Dig Endosc. 2013;25:313–21.
pubmed: 23611478 doi: 10.1111/j.1443-1661.2012.01393.x
Ohya T, Tazuma S, Kanno K, et al. A nation-wide survey of hepatolithiasis. J Jpn Biliary Assoc. 2013;27:788–794 (in Japanese with English abstract)
Yoon YS, Han HS, Shin SH, et al. Laparoscopic treatment for intrahepatic duct stones in the era of laparoscopy: laparoscopic intrahepatic duct exploration and laparoscopic hepatectomy. Ann Surg. 2009;249:286–91.
pubmed: 19212183 doi: 10.1097/SLA.0b013e31818eea56
Lai EC, Ngai TC, Yang GP, et al. Laparoscopic approach of surgical treatment for primary hepatolithiasis: a cohort study. Am J Surg. 2010;199:716–21.
pubmed: 19959158 doi: 10.1016/j.amjsurg.2009.02.007
Tu JF, Jiang FZ, Zhu HL, et al. Laparoscopic vs open left hepatectomy for hepatolithiasis. World J Gastroenterol. 2010;16:2818–23.
pubmed: 20533604 pmcid: 2883140 doi: 10.3748/wjg.v16.i22.2818
Ministry Of Health, Labour and Welfare. Research and Study on Refractory Liver and Biliary Diseases Tokyo: Bunkodo; 2011;32–59 (in Japanese).
Li EL, Yuan RF, Liao WJ, et al. Intrahepatic bile duct exploration lithotomy is a useful adjunctive hepatectomy method for bilateral primary hepatolithiasis: an eight-year experience at a single centre. BMC Surg. 2019;19:16.
pubmed: 30717712 pmcid: 6360740 doi: 10.1186/s12893-019-0480-1
Uchiyama K, Kawai M, Ueno M, et al. Reducing residual and recurrent stones by hepatectomy for hepatolithiasis. J Gastrointest Surg. 2007;11:626–30.
pubmed: 17468921 doi: 10.1007/s11605-006-0024-8
Otani K, Shimizu S, Chijiiwa K, et al. Comparison of treatments for hepatolithiasis: hepatic resection versus cholangioscopic lithotomy. J Am Coll Surg. 1999;189:177–82.
pubmed: 10437840 doi: 10.1016/S1072-7515(99)00109-X

Auteurs

Naotaka Fujita (N)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan. docfujita@gmail.com.
Miyagi Medical Check-up Plaza, 1-6-9 Oroshi-machi, Wakabayashi-ku, Sendai, Miyagi, 984-0015, Japan. docfujita@gmail.com.

Ichiro Yasuda (I)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Itaru Endo (I)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Hiroyuki Isayama (H)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Takuji Iwashita (T)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Toshiharu Ueki (T)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Kenichiro Uemura (K)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Akiko Umezawa (A)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Akio Katanuma (A)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Yu Katayose (Y)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Yutaka Suzuki (Y)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Junichi Shoda (J)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Toshio Tsuyuguchi (T)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Toshifumi Wakai (T)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Kazuo Inui (K)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Michiaki Unno (M)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Yoshifumi Takeyama (Y)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Takao Itoi (T)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Kazuhiko Koike (K)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Satoshi Mochida (S)

Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Cholelithiasis'', The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH